Performance analysis of Larimar Therapeutics (LRMR)
Annual Return
Over the past 3 years, LRMR has had an average annual return of +6.02%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, LRMR has had an average annual return of -17.40%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, LRMR has had an average annual return of -19.94%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Jun 19, 2014, LRMR has had an average annual return of -28.89%, underperforming the benchmark SPY, which returned +13.54% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.62% | -1.23% | -15.10% | +10.34% | -61.76% | -49.61% | +60.68% | -77.57% | +7.14% | +45.28% | -49.45% | -79.60% |
| 2014 | |||||||||||
| +56.15% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.45% | +50.34% | -15.18% | -10.00% | -14.04% | -12.24% | +25.58% | +0.62% | |||||
| 2025 | -0.61% | -20.99% | -28.91% | +23.08% | -15.18% | +28.42% | +19.67% | +4.79% | -11.11% | +20.59% | -9.15% | +8.05% | -1.23% |
| 2024 | +27.08% | +98.77% | -34.02% | -9.06% | +16.15% | -9.47% | +15.69% | -5.65% | -17.37% | +25.72% | -23.05% | -38.95% | -15.10% |
| 2023 | +19.54% | +23.08% | -25.39% | +4.71% | -22.00% | -15.38% | +37.12% | -13.26% | +6.37% | -25.75% | +16.94% | +32.41% | +10.34% |
| 2022 | -10.11% | -55.01% | -7.07% | -8.19% | -30.57% | -23.85% | -8.43% | +51.32% | +17.39% | +2.96% | -3.60% | +29.85% | -61.76% |
| 2021 | -26.58% | +8.60% | -14.44% | -8.77% | -37.54% | +17.95% | +1.21% | +44.87% | -19.93% | +3.70% | -23.02% | +17.27% | -49.61% |
| 2020 | +3.56% | -0.86% | -32.41% | +4.62% | +27.21% | +4.43% | -14.39% | +11.85% | +23.31% | +23.91% | +18.28% | -3.73% | +60.68% |
| 2019 | -10.30% | +0.67% | -38.71% | -6.56% | -28.47% | -34.95% | -23.55% | -9.33% | -10.53% | +0.27% | +9.33% | +37.07% | -77.57% |
| 2018 | +48.70% | +14.43% | -5.23% | -8.85% | +4.13% | +44.69% | +1.66% | -8.47% | +22.80% | -16.95% | -48.09% | -1.80% | +7.14% |
| 2017 | +32.42% | -5.72% | +17.36% | +4.75% | -30.55% | +3.55% | -3.71% | +6.84% | -2.52% | +1.18% | +9.82% | +18.13% | +45.28% |
Drawdown analysis of Larimar Therapeutics (LRMR)
The maximum drawdown for the LRMR was -99.75%, occurring on Aug 5, 2022. This drawdown has not yet recovered.
The current LRMR drawdown is -99.38%.
Since Jun 19, 2014 LRMR has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 7 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.75% | Mar 19, 2015 | 1859 | Aug 5, 2022 | Ongoing | Ongoing | Ongoing |
| -22.18% | Sep 2, 2014 | 30 | Oct 14, 2014 | 12 | Oct 30, 2014 | 42 |
| -16.93% | Jan 8, 2015 | 8 | Jan 21, 2015 | 3 | Jan 26, 2015 | 11 |
| -12.88% | Jun 23, 2014 | 33 | Aug 8, 2014 | 14 | Aug 28, 2014 | 47 |
| -12.79% | Oct 30, 2014 | 4 | Nov 5, 2014 | 13 | Nov 24, 2014 | 17 |
| -11.16% | Jan 27, 2015 | 7 | Feb 5, 2015 | 11 | Feb 23, 2015 | 18 |
| -10.01% | Feb 23, 2015 | 1 | Feb 24, 2015 | 10 | Mar 10, 2015 | 11 |
| -8.21% | Nov 28, 2014 | 12 | Dec 16, 2014 | 1 | Dec 17, 2014 | 13 |
| -3.27% | Dec 26, 2014 | 2 | Dec 30, 2014 | 4 | Jan 6, 2015 | 6 |
| -1.19% | Mar 12, 2015 | 1 | Mar 13, 2015 | 1 | Mar 16, 2015 | 2 |
| -0.99% | Aug 28, 2014 | 1 | Aug 29, 2014 | 1 | Sep 2, 2014 | 2 |